To view or add a comment, sign in A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy without adding side effects in a mid-stage clinical trial, pointing to a powerful new combination approach to tackling obesity
Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration
It suppresses the generation of angiotensin I and II, inhibiting the renin-angiotensin-aldosterone system to reduce blood pressure
However, for some, it may take several months to see the results
The lump is probably benign and can be caused by swelling, bruising, or a hematoma at the injection site
What is RGN-352 and what were the clinical trial outcomes for TB-500/Thymosin Beta-4